Hitachi elected by Sumitomo Dainippon Pharma for Automated Culture Equipment
BioSpectrum Asia & India | April 12, 2017
Hitachi has received an order for automated cell mass culture equipment for regenerative medicine using human iPS cells from Sumitomo Dainippon Pharma Co.